Glenn Greenberg Brave Warrior Advisors
Glenn Greenberg is the founder of Brave Warrior Advisors, a concentrated equity firm that evolved from earlier vehicles including Chieftain Capital. He is known for in-depth research, relatively few holdings, and a focus on businesses with strong competitive positions. Greenberg’s portfolio disclosures attract investors who follow classic fundamental concentration.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinix
EQIX
|
+$98.1M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$79.7M |
| 3 |
Bausch Health
BHC
|
+$58.4M |
| 4 |
Microsoft
MSFT
|
+$34.6M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$29.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halliburton
HAL
|
+$257M |
| 2 |
KMR
KINDER MORGAN MANAGEMENT LLC
KMR
|
+$35.3M |
| 3 |
Primerica
PRI
|
+$840K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 43.86% |
| 2 | Technology | 21.03% |
| 3 | Financials | 15.56% |
| 4 | Energy | 9.28% |
| 5 | Industrials | 5.92% |
Similar funds
Glenn Greenberg's Q2 2014 Portfolio in Review
As of Q2 2014, Glenn Greenberg held 13 positions worth $2.48B, up 0.22% from $2.47B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Glenn Greenberg's Q2 2014 filing shows 1 new, 6 increased and 3 reduced positions. Its largest new stake was Equinix: 509,260 shares worth $107M. The largest sale was Halliburton, an estimated $257M.
By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 41% a quarter earlier, followed by Technology and Financials.
- Glenn Greenberg's largest Q2 2014 buy was Equinix: 509,260 shares worth $107M.
- Glenn Greenberg added most to Express Scripts Holding Company in Q2 2014, an estimated $79.7M increase.
- Glenn Greenberg's biggest Q2 2014 reduction was Halliburton, cutting an estimated $257M.
- Glenn Greenberg's ten largest holdings make up 100% of its $2.48B portfolio in Q2 2014.
- Glenn Greenberg opened 1 new position and closed 0 in Q2 2014.
- Glenn Greenberg's portfolio value rose 0.22% quarter-over-quarter to $2.48B.
Based on Brave Warrior Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.